NMA: Nonprescription Medicines Academy

Recent Self Care News

  • Patient Safety Alert

    Glucose test strips that use the reagent glucose dehydrogenase pyrroloquinolone quinine (GDH-PQQ) can cause falsely elevated blood glucose results in patients who receive therapeutic products that contain or are metabolized to maltose, xylose, galactose, or certain other nonglucose sugars.

    August 31st, 2009

  • New Product Alerts

    Zicam Zavors, Liqui-Loz
    The Zicam line has expanded to include two new cherry-flavored oral zinc cold remedy products. Zicam Zavors are chews with a crunchy shell and soft center. Zicam Liqui-Loz are lozenges with a liquid center.

    August 31st, 2009

  • Nonprescription Medications Involved in Many Unintentional Pediatric Overdoses

    Commonly available OTC products are involved in more than one third of unintentional pediatric overdoses that prompt emergency department visits each year, according to an analysis of data from the Consumer Product Safety Commission’s National Electronic Injury Surveillance System (NEISS).

    August 31st, 2009

  • Little Evidence to Support Use of Topical Salicylates

    A recent Cochrane systematic review found little evidence supporting the use of topical rubefacients for musculoskeletal pain in adults

    August 31st, 2009

  • “Convincing” Evidence Supports Benefits of Fish Oils

    A “state of the art” review in Journal of the American College of Cardiology found convincing evidence from extensive research over the past 30 years to support beneficial effects of omega-3 polyunsaturated acids (PUFAs) in both primary and secondary prevention of cardiovascular diseases.

    August 31st, 2009

  • Probiotics May Reduce Cold and Flu Symptoms in Young Children

    In a study of children 3 to 5 years of age, daily probiotic consumption during the winter months proved to be a safe and effective strategy for reducing the incidence and duration of fever, rhinorrhea, and cough. Use of probiotics also reduced the number of antibiotic prescriptions and missed school days.

    August 31st, 2009

  • NSAIDs Recommended for Relieving Pain or Discomfort Caused By the Common Cold

    NSAIDs improve most analgesia-related symptoms caused by the common cold, but there is no clear evidence that they relieve respiratory symptoms such as cough and nasal discharge, according to a recent Cochrane systematic review.

    August 31st, 2009

  • Changes Ahead for Nonprescription Analgesics

    The FDA has issued a final rule that affects the labeling of all nonprescription analgesics now and recommendations that may affect acetaminophen in the future.

    July 9th, 2009

  • SPF: How High Is High Enough?

    With the advent of sunscreen products carrying sun protection factor (SPF) values of 70, 85, and even 100+, does higher equal better?

    July 9th, 2009

  • New Product Alerts

    Prevacid 24HR
    The FDA has approved an Rx-to-OTC switch of the proton pump inhibitor lansoprazole. The 15-mg, delayed-release capsules will be marketed as Prevacid 24HR by Novartis and are expected to be available later in 2009.

    Today Vaginal Contraceptive Sponge
    The Today Vaginal Contraceptive Sponge—a soft polyurethane sponge that releases the spermicide nonoxynol 9 continuously for 24 hours—has returned to the market for the third time. Mayer Laboratories acquired the Today Sponge after the previous manufacturer went bankrupt; the product was relaunched in May 2009.

    Besivance

    July 9th, 2009